Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CX-046684 for Covid-19 immunisation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where CX-046684 was used for Covid-19 immunisation.

Most Reported Side Effects for CX-046684

Side Effect Reports % Deaths Hosp.
Fatigue 23 46.0% 0 6
Off label use 15 30.0% 0 3
Covid-19 14 28.0% 0 4
Headache 13 26.0% 0 2
Asthenia 12 24.0% 0 4
Muscular weakness 12 24.0% 0 7
Pain in extremity 11 22.0% 0 3
Dysphagia 10 20.0% 0 2
Dyspnoea 10 20.0% 0 3
Fall 10 20.0% 0 4
Drug ineffective 9 18.0% 0 3
Insomnia 9 18.0% 0 3
Gait disturbance 8 16.0% 0 1
Malaise 8 16.0% 0 1
Peripheral swelling 8 16.0% 0 2

Other Indications for CX-046684

Product used for unknown indication (19) Covid-19 prophylaxis (12)

Other Drugs Used for Covid-19 immunisation

TOZINAMERAN (4,585) COVID-19 VACCINE NOS (1,641) ELASOMERAN (1,258) AZD-1222 (1,166) CX-024414 (385) COVID-19 VACCINE (305) AD26.COV2.S (190) NIRMATRELVIR\RITONAVIR (108) RAXTOZINAMERAN (43) BRETOVAMERAN (39)

Related Pages

CX-046684 Full Profile All Covid-19 immunisation Drugs CX-046684 Demographics CX-046684 Timeline